• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PRODUCTOS PARA EL CUIDADO DE LA SALUD -9611590 ARTICGEL PADS ARCTIC SUN PADS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PRODUCTOS PARA EL CUIDADO DE LA SALUD -9611590 ARTICGEL PADS ARCTIC SUN PADS Back to Search Results
Device Problem Device Operates Differently Than Expected (2913)
Patient Problems Stroke/CVA (1770); Edema (1820); Inflammation (1932); Necrosis (1971); Rash (2033); Sepsis (2067); Tissue Damage (2104); Toxic Shock Syndrome (2108); Skin Tears (2516)
Event Date 05/10/2017
Event Type  Injury  
Manufacturer Narrative
The device was not returned for evaluation. The lot number is unknown; therefore, the device history record could not be reviewed. Although the product family is unknown, the artic gel pad product ifus are found to be adequate based on past reviews. (b)(4).
 
Event Description
It was reported that a patient experienced skin peeling after receiving therapy on the arctic sun device. The skin was peeling on the thighs and abdomen when the pads were removed. There was also skin peeling on the arms and hands where the pads were not placed. Mepelex ag silver sheets were applied to the skin. Therapy was initiated for fever suppression. The patient had an autoimmune inflammatory disorder and acute exacerbation upon admission. The skin team was consulted before arctic sun therapy was initiated, due to the spreading purpuric rash related to critical thrombocytopenia on the abdomen and thighs. The patient was in fulminant sepsis requiring triple vasopressor therapy for hypotensive toxic shock at the time of arctic sun therapy. Therapy began on (b)(6) 2017 and continued until (b)(6) 2017 for 32 hours and 28 minutes. Therapy was discontinued for approximately one hour, so the patient could undergo a computerized tomography (ct) scan. Therapy was again initiated on (b)(6) 2017, and continued until later that day for 11 hours and 56 minutes. The patient was on the arctic sun device with serial number (b)(4). The patient was admitted on (b)(6) 2017 for stroke with hemorrhagic conversion, as a confirmed by the admitting physician. There was a vascath placed in the right groin area on the patient for continuous renal replacement therapy on an unknown date. The patient experienced toxic shock syndrome with, super (b)(6)in the blood on (b)(6) 2017. The cooling methods used prior to arctic sun treatment included a bair hugger and a gaymar cooling blanket. The patient received paralytics and versed for shivering. The patient also presented with left arm gross edema, consistent with necrosis and digit loss of fingers and toes.
 
Manufacturer Narrative
The investigation is still in progress. Once the investigation is complete a supplemental report will be filed. The information provided by bard represents all of the known information at this time. Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard. The device was not returned.
 
Event Description
It was reported that a patient experienced skin peeling after receiving therapy on the arctic sun device. The skin was peeling on the thighs and abdomen when the pads were removed. There was also skin peeling on the arms and hands where the pads were not placed. Mepelex ag silver sheets were applied to the skin. Therapy was initiated for fever suppression. The patient had an autoimmune inflammatory disorder and acute exacerbation upon admission. The skin team was consulted before arctic sun therapy was initiated, due to the spreading purpuric rash related to critical thrombocytopenia on the abdomen and thighs. The patient was in fulminant sepsis requiring triple vasopressor therapy for hypotensive toxic shock at the time of arctic sun therapy. Therapy began on (b)(6) 2017 and continued until (b)(6) 2017 for 32 hours and 28 minutes. Therapy was discontinued for approximately one hour, so the patient could undergo a computerized tomography (ct) scan. Therapy was again initiated on (b)(6) 2017, and continued until later that day for 11 hours and 56 minutes. The patient was on the arctic sun device with serial number (b)(4). The patient was admitted on (b)(6) 2017 for stroke with hemorrhagic conversion, as a confirmed by the admitting physician. There was a vascath placed in the right groin area on the patient for continuous renal replacement therapy on an unknown date. The patient experienced toxic shock syndrome with, super (b)(4) sepsis in the blood on (b)(6) 2017. The cooling methods used prior to arctic sun treatment included a bair hugger and a gaymar cooling blanket. The patient received paralytics and versed for shivering. The patient also presented with left arm gross edema, consistent with necrosis and digit loss of fingers and toes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand NameARTICGEL PADS
Type of DeviceARCTIC SUN PADS
Manufacturer (Section D)
PRODUCTOS PARA EL CUIDADO DE LA SALUD -9611590
km. 7 carretera internacional
nogales, sonora 85621
MX 85621
Manufacturer (Section G)
PRODUCTOS PARA EL CUIDADO DE LA SALUD -9611590
km. 7 carretera internacional
nogales, sonora 85621
MX 85621
Manufacturer Contact
amy gravley
8195 industrial blvd
covington, GA 30014
7707846100
MDR Report Key6614802
MDR Text Key196665069
Report Number1018233-2017-02938
Device Sequence Number1
Product Code DWJ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K142702
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,other
Reporter Occupation
Type of Report Initial,Followup
Report Date 07/12/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/06/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA?
Event Location No Information
Date Manufacturer Received06/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial

Patient Treatment Data
Date Received: 06/06/2017 Patient Sequence Number: 1
-
-